A multicentre, randomized, double-blind, placebo-controlled, 1-year study of bupropion SR for smoking cessation

Philip Tønnesen, S. Tonstad, A. Hjalmarson, F. Lebargy, P. I. Van Spiegel, A. Hider, R. Sweet, J. Townsend

Research output: Contribution to journalArticlepeer-review

Original languageEnglish
Pages (from-to)184-192
Number of pages9
JournalJournal of Internal Medicine
Volume254
Issue number2
DOIs
StatePublished - Aug 1 2003
Externally publishedYes

ASJC Scopus Subject Areas

  • Internal Medicine

Keywords

  • Bupropion sustained release
  • Randomized controlled trials
  • Smoking cessation
  • Weight gain
  • Withdrawal symptoms
  • Nicotine/metabolism
  • Double-Blind Method
  • Humans
  • Middle Aged
  • Bupropion/adverse effects
  • Male
  • Treatment Outcome
  • Delayed-Action Preparations/therapeutic use
  • Substance Withdrawal Syndrome/psychology
  • Dopamine Uptake Inhibitors/adverse effects
  • Smoking Cessation/methods
  • Adult
  • Female
  • Weight Gain/drug effects

Cite this